en plénière

Martine Baudin, Première Ligne, Genève

As a social worker I worked with adult clients in different settings and in various mandates (adults psychiatry, financial assistance, with a commitment to promote the formation of young people in difficulties.
I have evolved in the field of harm reduction since 1993. In 2003 I took over the coordination of the Quai 9 facility and in 2010 was named Head of the association Première Ligne.
S2: Harm reduction work in Switzerland: which direction to take?

Dirce Blöchlinger, VEVDAJ

Active in family support for more than 20 years (information, coping strategies, counselling). Presentations and workshops on how addiction affects families. Drug prevention in schools. Member of the Empowerment Group of the Correlation Europe Project since three years. Member of the Foundation Board of Contact Network Bern. Board member of VEVDAJ.
S3: What does harm reduction mean to parents and other family members?

Joanne Csete, Global Drug Policy Program | Open Society Foundations

Deputy director, Global Drug Policy Program; formerly Assoc. Professor of health and human rights, Columbia University (USA); founding director of the HIV and Human Rights Program, Human Rights Watch, New York; former executive director, Canadian HIV/AIDS Legal Network.
S7: What does successful drug policy advocacy mean for harm reduction?

Carlo Fabian, Institut Sozialplanung und Stadtentwicklung, Hochschule für Soziale Arbeit, Fachhochschule Nordwestschweiz

Carlo Fabian, lic. phil., social and health psychologist. Research associate & project manager at the Institute for Social Planning and Urban Development (School of Social Work, University of Applied Sciences Northwestern Switzerland FHNW). Many years of research and evaluation experience at the University of Zurich, the Zurich Institute of Addiction Research, and the University of Applied Sciences Northwestern Switzerland as well as practical work in the field for RADIX, Swiss Foundation for Health Promotion and Prevention. Head of several evaluation and research projects followed by concept work on health promotion, prevention for children and youths. Contributed to the implementation of various health promotion and prevention projects in Switzerland (e.g. evaluation and development of early detection and early intervention projects in schools and communities, development of a tool for situation analysis and needs determination for health promotion and prevention in communities). Teaching experience: psychology, prevention, communication, research methods, and evaluation.
S5: Between everyday life and drug policy: the importance of the social space

Ann Fordham, International Drug Policy Consortium

Ann Fordham is the Executive Director of the International Drug Policy Consortium (IDPC, Ann has largely contributed to international advocacy efforts on drug policy and human rights, specifically calling for reform of laws and policies that have proven ineffective in reducing the scale of the drug market and have negatively impacted vulnerable population groups, such as people who use drugs and growers of illicit crops. She has worked with policy makers around the world to review and shape drug control policies towards more humane, effective approaches that are based in principles of human rights and public health.
Ann has a Masters Degree in Human Rights from Sussex University where she specialized in human rights and harm reduction. Her previous role was at the International HIV/AIDS Alliance where she was engaged in policy work around prevention, treatment and care for people who use drugs.
S6: The 2016 UNGASS on drugs: Why we need a strong European voice

Alexander Grabenhofer-Eggerth, Gesundheit Österreich GmbH

- Psychologist, epidemiologist, scientific researcher
- Staff member of Gesundheit Österreich GmbH /Austrian REITOX Focal Point since 2008: Coordinator of the Austrian treatment demand documentation system (EMCDDA key indicator treatment demand), Coordinator of the Austrian early warning system on new psychoactive substances, Co-author of the Austrian report on the drug situation since 2009
- Lecturer on addiction prevention – University/FH Linz
- 12 years’ experience in drug-related research
- 7 years of practical experience with counselling in the field of harm reduction in a low-threshold service
S4: Evidence and availability of harm reduction in Europe 2003-2013

Dagmar Hedrich, Observatoire européen des drogues et des toxicomanies

Psychologist by training; postgraduate qualification as addiction therapist. Worked as researcher in longitudinal study on treatment outcome and self-recovery; municipal drugs division Frankfurt; Council of Europe Pompidou Group; since 2001 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in charge of developing and improving data collection on health and social responses to drug use in Europe.
S4: New trends in harm reduction in Europe: progress made – challenges ahead

Martin Jelsma, Transnational Institute – TNI

Martin Jelsma has directed TNI’s Drugs & Democracy Programme since its start in 1995. The programme has been analysing trends in the illegal drugs market and in drug policies globally. The programme has gained a reputation as one of the leading international drug policy research institutes and a serious critical watchdog of the UN drug control institutions. Jelsma is an advisor of the Global Commission on Drug Policy, a member of the “scenario team” of the Organization of American States and regularly advises governments on drug law reform options. A recent publication of his is “The Rise and Decline of Cannabis Prohibition – the history of cannabis in the UN drug control system and options for reform”.
More information:,, and @MartinJelsmaTNI
S6: Cannabis regulation and UN treaty reform

Annie Machon, Law Enforcement Against Prohibition

Annie Machon is a former intelligence officer for MI5, the UK Security Service, who resigned in 1996 to blow the whistle on the spies’ incompetence and crimes. Drawing on her varied experiences, she is now a media pundit, author, journalist, political campaigner, and PR consultant.
S7: Law Enforcement Against Prohibition – the “war on drugs” has failed

Anne Philibert, Université de Genève

Anne Philibert is associate researcher in sociology at the University of Geneva. During her studies, she worked on migrant workers affected by tuberculosis and on AIDS prevention among sex workers, to name only two examples. Her main research subjects are the development of standards in the field of addiction as well as regulatory policies.
S7: Government paternalism: to what extent?

Dirk Schäffer, Deutsche AIDS-Hilfe

Until 2001 national coordinator of the German drug user network JES (Junkies, Ex-users, people in opiate Substitution treatment).
Since 2001 head of the division “Drug use and prison issues”. Founder of “Action group hepatitis and drug use”.
S4: Hepatitis C / HIV: prevalence and access, any changes?

Heino Stöver, Institut für Suchtforschung, Fachhochschule Frankfurt am Main

Heino Stöver is a social scientist, PhD and Professor of Social Scientific Addiction Research at the University of Applied Sciences in Frankfurt am Main, Germany, Faculty of Health and Social Work. He is the President of the national umbrella organisation working in the field of harm reduction for drug users called akzept e.V.
Heino Stöver’s main fields of research and project development expertise are health promotion for vulnerable groups, drug services, prisons and related health issues (especially HIV/AIDS, hepatitis C and drug addiction). His research and consultancy expertise include working as a consultant for the European Committee of the Red Cross (ICRC) and the Open Society Institute (OSI) in various contexts.
He has published several articles in peer reviewed international journals and books on preventing and treating infectious diseases adequately (HIV/AIDS, hepatitis, STIs, and TB), opioid substitution programmes in the community and in prisons, and general health care issues in prisons.
S2: Pushing the boundaries of harm reduction

Adam R. Winstock, South London and Maudsley NHS Trust and Institute of Psychiatry, Kings College London

Adam is a Consultant Addiction Psychiatrist at the South London and Maudsley NHS Trust and Honorary Senior Lecturer at the Institute of Psychiatry, Kings College London. He has written over a 100 papers, monographs and book chapters. He is also founder and director of Global Drug Survey which runs the world’s biggest annual survey of drug use trends and is also the architect of the on line and smart phone apps the drugs meter ( and drinksmeter ( Adam thinks any dialogue about harm reduction needs to start with a conversation about pleasure. He is interested in applying behavioural economics, social normative feedback to drug use and helping to craft optimal public health responses to drugs.
S4: New approaches to harm reduction – drugs meter, drinks meter and the High Way Code